Trial intelligence / Profile preview

Tiotropium Respimat vs HandiHaler in COPD Sleep Quality

NCT02331940Completed

Sponsor
University of Crete
Start
Mar 2010
Primary completion
Dec 2013
Modality
Small Molecules
01

Overview

Randomised trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by University of Crete. Primary endpoint: Sleeping Oxygen Saturation at 26 weeks. Started Mar 2010; status: completed.

02

Drugs

tiotropium
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02331940.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02331940.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call